Whole-brain radiotherapy (WBRT) and high-dose methylprednisolone (HDMP) for elderly patients with primary central nervous system lymphoma (PCNSL): Results of North Central Cancer Treatment Group (NCCTG) 96-72-51

被引：0
|
作者：
Laack, N
Ballman, KV
Brown, PB
O'Neill, BP
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1007
引用
收藏
页码：S260 / S261
页数：2
相关论文
共 50 条
  • [21] THERAPY OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) WITH METHOTREXATE (MTX)-BASED INTRAVENOUS CHEMOTHERAPY (MBISC) AND DEFERRED WHOLE-BRAIN RADIATION-THERAPY (WBRT)
    CHER, L
    GLASS, J
    HOCHBERG, FH
    NEUROLOGY, 1994, 44 (04) : A378 - A379
  • [22] Primary central nervous system non-Hodgkin's lymphoma (PCNSL): Survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) study 86-72-52
    O'Neill, BP
    Wang, CH
    O'Fallon, JR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (03): : 559 - 563
  • [23] Combination immunochemotherapy followed by reduced dose (rd) whole brain radiation therapy (WBRT) in an expanded cohort of patients with newly diagnosed primary central nervous system lymphoma (PCNSL)
    Abrey, L. E.
    Correa, D.
    Yahalom, J.
    Raizer, J.
    Grimm, S.
    Lai, R.
    Schiff, D.
    Grant, B.
    DeAngelis, L. M.
    Morris, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy
    Bagal, Bhausaheb
    Sarma, Rup
    Dey, Sayak
    Nayak, Lingaraj
    Bonda, Avinash
    Goda, Jayant
    Khanna, Nehal
    Dasgupta, Archya
    Kakoti, Sangeeta
    Chatarjee, Abhishek
    Jain, Hasmukh
    Epari, Sridhar
    Laskar, Siddhartha
    Sengar, Manju
    Gupta, Tejpal
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 150 - 153
  • [25] The role of whole brain radiotherapy in primary management of patients with primary central nervous system lymphoma (G-PCNSL-SG1 trial)
    Korfel, A.
    Weller, M.
    Martus, P.
    Kanz, L.
    Griesinger, F.
    Rauch, M.
    Fischer, L.
    Pietsch, T.
    Bamberg, M.
    Thiel, E.
    ONKOLOGIE, 2010, 33 : 99 - 99
  • [26] TOLERANCE OF HIGH-DOSE METHOTREXATE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) PATIENTS WITH RENAL IMPAIRMENT, CASE SERIES AND REVIEW OF LITERATURE
    Zhu, Jay-Jiguang
    Chinea, Luis
    Quintero, Juan Carlos Rodriguez
    NEURO-ONCOLOGY, 2022, 24 : 193 - 193
  • [27] A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma
    Suzuki, Yutaro
    Imoto, Naoto
    Ishihara, Shunichi
    Fujiwara, Shinji
    Ito, Rie
    Sakai, Toshiyasu
    Yamamoto, Satomi
    Sugiura, Isamu
    Kurahashi, Shingo
    INTERNAL MEDICINE, 2022, 61 (09) : 1345 - 1352
  • [28] Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma
    Foreman, Bronwen E.
    Mullikin, Trey C.
    Floyd, Scott R.
    Kelsey, Chris R.
    Patel, Mallika P.
    Peters, Katherine B.
    Kirkpatrick, John P.
    Reitman, Zachary J.
    Vaios, Eugene J.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [29] A sequential administration of high dose methotrexate (HDMTX) - and high dose cytarabin (HDAraC)-based chemotherapy in elderly patients with primary central nervous system lymphoma (PCNSL)
    Sumbul, M.
    Le Coutre, P.
    Schluz, C-O
    Seidel, S.
    Margold, M.
    Martus, P.
    Mathas, S.
    Janz, M.
    Schlegel, U.
    Korfel, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 75 - 75
  • [30] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
    Yasufumi Masaki
    Miyuki Miki
    Yue Sun
    Takuji Nakamura
    Haruka Iwao
    Akio Nakajima
    Nozomu Kurose
    Tomoyuki Sakai
    Zhe-Xiong Jin
    Toshioki Sawaki
    Takafumi Kawanami
    Yoshimasa Fujita
    Masao Tanaka
    Toshihiro Fukushima
    Yuko Hirose
    Hisanori Umehara
    International Journal of Hematology, 2011, 93 : 720 - 726
12345